cluster of genes were then identified using a Fisher's exact test. The P values of pathways were then adjusted for multiple comparisons using the BH method.
Introduction
The introduction of combination antiretroviral therapy (cART) has had a major impact on the morbidity and mortality of HIV-1-infected individuals. Nonetheless, despite effective control of HIV replication with cART, a minority of treated individuals fails to show increased CD4 + T cell counts to the levels observed in uninfected subjects (1, 2) . These immune failure or immune nonresponder (INR) subjects remain at greater risk for morbidity and mortality than do immune responder (IR) subjects in whom the CD4 + T cell count is restored (3, 4) . Although the precise determinants of immune failure are not well defined, several characteristics of immune cells define this syndrome and may provide insight into these mechanisms. High levels of T cell activation and cycling have been observed in many lymphopenic systems (5) . INRs have high levels of T cell activation, defined by the coexpression of CD38 and HLA-DR on CD4 + and CD8 + T cells, as well as elevated expression of inflammatory markers in plasma (1) . INRs also have profound decreases in circulating naive CD4 + and CD8 + T cells (1, 6, 7) , and their lymphocytes have poor in vitro responses to IL-7 (8) (9) (10) (11) . Age (12, 3) , nadir CD4 + T cell counts (14, 15) , longer duration of HIV-1 infection (12, 3) , microbial translocation and inflammation (1) , and poor responses to IL-7 (8) (9) (10) (11) have all been associated with the failure to restore CD4 + T cell numbers in INR subjects. Hepatitis C virus (HCV) coinfection has also been linked to low CD4 + T cell counts in some (16) but not all studies (17) . Despite low CD4 + T cell numbers and poor IL-7 responsiveness, an increased frequency of cycling CD4 + T cells is characteristic of INRs (1, 2) . To better understand the characteristics of cycling CD4 + T cells in INRs, we used surface CD71 as a specific marker of cells in cycle and examined the transcriptional profile of cycling and noncycling memory CD4 + T cells from INRs, IRs, and healthy controls (HCs). We found that in each subject population, cycling CD4 + T cells were enriched for cells with the transcriptional profile and phenotype of Tregs, and we detected an apoptotic gene signature in cycling CD4 + T cells from INRs, but not in cycling cells from HCs or IRs. We also found that the impaired Treg homeostasis was linked to decreased CD4 + T cell counts in treated HIV + T cells ( Figure 2B ). Finally, the proportion of Tregs among cycling memory CD4 + T cells and the peripheral CD4 + T cell count (in IRs and INRs) were positively correlated in the HIV + subjects ( Figure 2C ). Although the frequencies of cycling CD4 + T cells were elevated in INRs compared with frequencies in IRs, the absolute numbers of both cycling and noncycling Tregs in circulation remained significantly lower in INRs than in IRs (Supplemental Figure 2C) . These data suggest a potentially important role of Tregs in the homeostatic maintenance of CD4 + T cell numbers (25) . The expression of genes that regulate Treg differentiation and function is suppressed in INRs. We then fit a linear model between Treg frequencies and gene expression pathways specific to Treg function (Supplemental Table 5 ). We found that the expression of genes specific to Treg function was associated with higher Treg frequencies in cycling memory CD4 + T cells (normalized enrichment score [NES] = 1.6, P < 0.05) ( Figure 3A) . The expression of genes upregulated by the master transcription factor of Treg differentiation and function FOXP3 (26) (i.e., CD2, TNFRSF4, CD83) was linked to increased frequencies of cycling effector Tregs and was lower in INRs (NES = 1.9, P < 0.05) ( Figure 3B ). These findings were extended to a signature that includes genes of the TGF-β signaling pathway (TGIF1, SMAD1, SMAD7, LEFTY) ( Figure 3C ). TGF-β controls the development, differentiation, and function of Tregs (27) (NES = 1.7, P < 0.05), which further validates our model.
Deletion of Tregs can lead to systemic inflammation (28, 29) , confirming their role in controlling inflammatory processes driven by type I IFNs (30, 31) . IFN-stimulated genes (ISGs) were upregulated in INRs, and overall, this was inversely associated with Treg frequencies in cycling memory CD4 + T cells (NES = -1.4, P < 0.05) ( Figure 3D ). To further explore Treg function in phenotypically defined Tregs among INRs, we measured the expression of glycoprotein A repetitions predominant (GARP) and latency-associated peptide (LAP) as surrogates of TGF-β secretion (32) . As shown in Figure 3F (and Supplemental Figure 3) , the frequencies and absolute numbers (Supplemental Figure 3B ) of cells expressing GARP and LAP among Tregs were significantly lower (P < 0.05) in INRs than in IRs, reflecting a diminished production of TGF-β by INR Tregs. Moreover, we established significant positive correlations between the numbers of peripheral CD4 + T cells and the frequencies of phenotypically defined Tregs expressing GARP and LAP in treated HIV infection (IRs plus INRs) (P = 0.02, rho = 0.4) ( Figure  3G ). Taken together, these data suggest that Treg production of TGF-β is impaired in the setting of immune nonresponse and suggest that Treg dysfunction may underlie CD4 + T cell homeostatic failure in treated HIV infection or is a consequence of it.
To explore the potential mechanisms for Treg dysfunction, we examined the oxidative phosphorylation (OXPHOS) pathway, which is associated with the development and maintenance of Tregs (33, 34) . We found that expression of OXPHOS genes was positively correlated with the increasing frequency of Tregs in cycling memory CD4 + T cells (NES = 2.1, P < 0.0001) ( Figure 3E ).
infection. Mitochondria are the energy powerhouse organelles, and their function is linked to cell survival and function (18) (19) (20) . Importantly, cycling Tregs from INR subjects showed decreased mitochondrial fitness and low expression of mitochondrial biogenesis regulators, the peroxisome proliferator-activated receptor γ coactivator 1-α (PGC1α), and the transcription factor A for mitochondria (TFAM). PGC1α is downregulated in settings of immune exhaustion such as that seen in murine lymphocytic choriomeningitis virus (LCMV) infection and in cancer models (21, 22 (23) and mouse T cells (24) . Here, we expand these findings to human CD4 + T cells, as we observed that cell-surface expression of CD71 was tightly correlated to intracellular expression of Ki67 (r = 0.9854) among CD4 + T cells (Supplemental Table 4 ) and downregulated genes that inhibit cell-cycle entry (e.g., CDKN2A, CDKN2B, CDKN1C) (Supplemental Figure 1D and Supplemental Table 4 ), thus validating the use of surface CD71 expression to identify CD4 + T cells in cell cycle. We also found significantly higher frequencies (P < 0.05) of phenotypically defined Tregs (FOXP3 nisms that could explain the low CD4 + T cell numbers observed in INRs. We monitored for differences in gene expression profiles of the cycling memory cells among the 3 groups and found that the gene expression profiles of the HCs and IRs were similar and dis-
Cycling CD4 + T cells from INRs have distinct gene expression profiles reflecting apoptotic signaling and inflammatory responses.
Having demonstrated that Treg dysfunction is characteristic of cycling CD4
+ T cells in INRs, we next explored potential mecha- Figure 5A ). Genes downregulated in cycling memory cells in INRs included COX8, COX5, COX6, and SURF1, which are known components of the mitochondrial respiratory chain; CPTA1 as well as PDK4, genes upstream of fatty acid oxidation (FAO); and IDH1 and IDH2, two enzymes that are critical for glucose-dependent energy production. We found that genes of the NADH family were also expressed at significantly lower levels in the INRs (P < 0.05).
To examine at the single-cell level the mitochondrial defects suggested by transcriptional profiling, we used MitoTracker Green (MG) and MitoTracker Orange (MO) dyes, which quantify mitochondrial mass and OXPHOS, respectively (see Methods). OXPHOS activity, measured by the mean fluorescence intensity (MFI) of MO, was significantly lower (P < 0.05) in cycling CD4 + tinct from those of the INR subjects (Supplemental Figure 4A and Supplemental Table 6 ). We then used the gap statistic approach (35) to identify the genes that showed distinct expression profiles among these groups and characterized pathways enriched among the genes (see Methods). This analysis revealed that the expression of proapoptotic genes in cycling CD4 + T cells was significantly (P < 0.05) upregulated specifically in the INRs when compared with expression of these genes in IRs and HCs ( Figure 4A ). Type I IFN triggers the expression of several proapoptotic genes (36) . Figure 4B shows that ISGs, including proapoptotic genes (IFI27, IFIT2, SAMD9), were significantly upregulated in cycling CD4 + T cells from INRs. As expected, higher expression of these ISGs was associated with lower absolute numbers of CD4 + T cells and, importantly, with lower frequencies of phenotypically defined Tregs among cycling memory CD4 + T cells (Supplemental Figure  4 , B and C, and These signatures, which were observed to be specific to the cycling memory cells of INRs, were not observed in their noncycling memory cell counterparts (data not shown).
These apoptotic gene signatures were relevant to cell survival, as in short-term culture experiments (Figure 4 , E and F) we found T cells from INR subjects ( Figure 5B ). This could not be attributed to differences in mitochondrial mass in cycling CD4 + T cells from HC, IR, or INR subjects ( Figure 5C ), as MG fluorescence was similar in the cycling cells from subjects of all groups analyzed. This analysis supported the transcriptional profiling analysis of cycling memory CD4 + T cells displayed in Supplemental Figure 5 and Figure 5A . When the mitochondrial analysis was restricted to cycling Tregs, the MFI of both MO and MG was significantly (P < 0.05) diminished in the INR subjects ( Figure 5 , D and E, and Supplemental Figure 6 ). This was specific to cycling Tregs, as we detected no differences in OXPHOS or mitochondrial mass among the subject groups in CD71 -Tregs or in CD71 + or CD71 -CD4 + T cells that were not Tregs (Supplemental Figure 7) .
PGC1α and TFAM expression is diminished in the cycling Tregs of INRs. We next evaluated by flow cytometry the expression of PGC1α, the master regulator of mitochondrial biogenesis (21, 22) , and TFAM, a regulator of expression of 13 mitochondrial genes implicated in OXPHOS (37) Figure 6C ). In contrast, as shown in Figure 6 , IL-2 had no effect on MG or MO fluorescence or the proliferation of INR Tregs. These data suggest that the mitochondrial dysfunction of cycling Tregs from INRs could be improved by IL-15 and that this was associated with induction of PGC1α and TFAM.
Discussion
Earlier work has found high frequencies of cycling among memory CD4 + T cells in HIV-infected subjects (38) (39) (40) . Effective combination antiretroviral therapy leads to a significant decrease in the numbers of cycling cells (1, 41) , however, among INRs, despite virologic control, memory CD4 + T cell cycling remains elevated. It is not clear whether this increased CD4 + T cell memory cycling is a homeostatic consequence of lymphopenia or a driver of CD4 lymphopenia by increasing T cell turnover and cell death. Thus, it is important to define the characteristics of cycling memory CD4 + T cells in INR subjects to ascertain whether this increased cycling reflects a "healthy" homeostatic response, or whether it is reflective of a pathophysiologic perturbation that contributes to immune dysregulation.
We show here that cycling memory CD4 + T cells obtained from INRs are incapable of completing the cell cycle and proliferating when incubated in culture medium ex vivo. Our ability to sort cycling cells on the basis of surface CD71 expression allowed us to study these cells in isolation and also allowed us to characterize their transcriptional profile. We found that in health and in HIV infection, cycling CD4 + T cells were enriched for Tregs as defined by both the transcriptional signature and phenotype.
We report lower frequencies of CD4 + T cells with a Treg phenotype in cycling memory CD4 + T cells in 2 independent INR cohorts, suggesting that these regulatory cells are not adequately sustained. (Figures 1-3) . Tregs proliferate at higher rates than do conventional CD4 + T cells in mice (42) (43) (44) and humans (45, 46). In humans, Tregs are maintained by a sustained proliferation, as demonstrated by deuterium uptake in vivo (45). The importance of Treg maintenance by proliferation was shown by Carbone et al. (25) , who found an impaired capacity of Tregs to proliferate in relapsing-remitting multiple sclerosis and linked diminished Treg expansion to increasing disease severity.
Whether circulating Tregs reflect the function of mucosal Tregs is still unclear. We have discussed elsewhere (47) and provide evidence here that the proinflammatory environment in INR individuals is linked to low numbers of circulating Tregs and functional dysregulation of those that remain. Earlier studies have reported low frequencies of Tregs in the gut mucosa (48) and lymphoid tissues (49) in INR subjects. Yet, from none of those findings can we determine the directionality of these relationships. Our new observations suggest that the maintenance of circulating Tregs is sustained by their ongoing proliferation, gene expression, and metabolic activity, which are linked to CD4 + T cell homeostasis. These indices also may be a more accurate reflection of Treg function than is the simple enumeration of Treg phenotype frequencies. Both the numbers and function of Tregs are diminished in the circulation of INRs, but the function of mucosal Tregs in this setting has not yet been studied.
Altogether, our data suggest that the diminished numbers and functional alterations of cycling Tregs are associated with a failure of CD4 + T cell recovery and an overall increase in CD4 + cell cycling but an impaired ability of these cycling cells to complete the cell cycle and divide in treated HIV-1 infection. Tregs in HIV-1-infected INR subjects and allowed dysfunctional cycling CD4 + T cells in INRs to complete the cell cycle and divide. These findings suggest that administration of IL-15, a cytokine in human trials for the treatment of cancer (50, 51) , could rescue functionally impaired Tregs, which bear features of an exhausted phenotype (52) in INR patients and enhance immune restoration in these subjects.
Methods
Study cohorts. Two cohorts of HIV-1-infected subjects were studied: a Perm, Russia, cohort (Supplemental Table 1 ) and a Cleveland, Ohio, USA, cohort (Supplemental Table 3 The median duration of cART was 4 years in both IR and INR groups. The Russian cohort's characteristics are detailed in Supplemental Table  1 . Listed in Supplemental Table 2 are the subjects for whom microarray transcriptomic analysis was performed. These subjects were selected from the Russian cohort on the basis of sample availability. Gene array analysis was performed on sorted CD3 We suspect that the increased CD4 + T cell cycling seen in INRs represents both a failed homeostatic response as well as a dysregulated control of cellular activation. Our data analysis has led us to build an integrative model (see Methods) that associates the low CD4 + T cell numbers with the interaction between metabolic pathways identified by gene expression and the maintenance of Tregs. The OXPHOS pathway, Treg signature, FOXP3-upregulated targets, and TGF-β signaling are all positively associated with the maintenance of cycling Tregs, which correlated to high CD4 + T cell numbers, while greater apoptosis and type I IFN signatures correlated to low CD4 + T cell numbers ( Figure 7 and Supplemental Table 7 ). It is interesting that IL-15 mRNA levels were increased in the transcriptional profile of INR cycling CD4 + T cells ( Figure 3D ), in which exogenous IL-15 could repair the mitochondrial defect observed. And though we have previously reported increased levels of IL-15 in lymphoid tissues of untreated HIV-infected individuals (23), CD4 + T cells are not thought to be important sources of IL-15. The significance of this observation is thus uncertain and should be explored.
IL-15 has been shown to induce the expression of carnitine palmitoyl transferase (CPT1A), a metabolic enzyme that controls the rate-limiting step to mitochondrial FAO and improves mitochondrial OXPHOS in mouse CD8 + T cells (18) . Our data are consistent with these findings, as we show that IL-15 induced the expression of PGC1α, the master regulator of many genes implicated in mitochondrial metabolism. PGC1α induces mitochondrial biogenesis in exhausted CD8 + T cells in murine viral infection (22) and murine cancer (21) models, leading to better CD8 + T cell function. Our data extend these findings to human systems, as we showed that the induction of PGC1α and TFAM by IL-15 was associated with increases in mitochondrial mass and OXPHOS of Statistical analysis of flow cytometric data. Wilcoxon rank-sum tests were used to determine statistical differences in pairwise comparisons. The P values were then adjusted for multiple comparisons using the Benjamini and Hochberg (BH) method.
Transcriptional profiling of microarray data. Analysis of the raw quantified microarray output data was conducted using Bioconductor R software. Missing gene expression data were imputed using nearestneighbor averaging (https://bioconductor.org/packages/release/bioc/ html/impute.html). Gene expression was quantile normalized and then log 2 transformed to reduce variability. Sample outliers based on gene expression were detected and removed. Hierarchical clustering methods and multidimensional scaling analysis were used to evaluate similarities or differences in gene expression profiles between samples.
To detect differences in gene expression between groups of interest, the LIMMA package (53) was used to fit a linear regression model to each probe, with transcript expression as the dependent variable and the group of interest as the independent variable. For each model, a moderated t test was used to test whether the fold changes were different from zero. The P values were then adjusted for multiple comparisons using the BH method (54) . To identify pathways enriched for the genes differentially expressed among the groups compared, gene set enrichment analysis (GSEA) (55) preranked by the decreasing order of the t statistic of the genes was performed. The Hallmark gene sets from the Molecular Signatures Database (MSigDB), along with a Treg signature (56) and target genes of FOXP3 (26) , were used as the pathway database. The P values of the enriched pathways were then adjusted using the BH method, and pathways with P values of less than 5% were reported.
To identify modules of cell-cycling pathways among the genes differentially expressed between cycling and noncycling memory cells in Table 3 .
Microarray. For microarray analysis, cryopreserved PBMCs from the Russian cohort of 6 HCs, 6 INRs, and 6 IRs (Supplemental Table 2 Table 7 .
each subject group, we grouped pathways into modules on the basis of at least 25% gene overlap (Jaccard index) between pathways using the enrichment map strategy (57) . The most frequent genes among the pathways in a module, defined as genes that were enriched in at least 50% of the pathways in each module, were represented. cells) by fitting a linear regression model with the transcript expression as a dependent variable and the outcome as an independent variable. The outcome was kept as a continuous variable. A moderated t test was performed to determine whether the coefficient of regression of each transcript was different from zero, and the obtained P values were adjusted for multiple comparisons using the BH method. To identify pathways among the genes associated with the outcomes, GSEA with 1,000 permutations was performed on genes preranked by the decreasing order of their t statistic using the Hallmark gene sets of MSigDB (55) . The P values of the enriched pathways were adjusted by the BH method, and pathways with P values of less than 5% were reported.
For the integrative model, a correlation between pathways and the outcomes was determined by sample-level enrichment analysis (SLEA) by calculating the Z score of each pathway per sample (58) . The mean expression value of genes of a selected pathway was compared with the mean expression of 1,000 random gene sets of the same size of the selected pathway for every sample. The difference between the observed and expected mean expression values for each gene set was calculated.
Gap statistic approach. We identified transcripts that were significantly (P < 0.05) differentially expressed among the 3 donor classes in the cycling cell population. Hierarchical clustering of these genes revealed 2 major clusters in which the gene expression profiles of the HCs and IRs were similar and distinct from those of the INRs. Clusters of genes that showed unique/distinct gene expression profiles in the 3 classes of subjects were identified using the gap statistic strategy (35) . Pathways (Hallmark gene sets from the MSigDB) specific to each
